Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

484
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
484
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

483
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
483
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

4.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.5K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

715
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
715
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

713
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
713

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[COPD inhaled therapy narrative review].

Semergen·2024
Same author

[Foot color change after COVID19].

Semergen·2021
Same author

[Migraines, candidiasis and acne. One solution].

Semergen·2018
Same author

[COPD, what is the best treatment?]

Semergen·2018
Same author

[Pruritus and rivaroxaban].

Semergen·2018
Same author

[Hereditary leiomyomatosis and renal cell cancer].

Semergen·2016

Related Experiment Video

Updated: Oct 21, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.9K

[COPD inhaled therapy narrative review].

A L Aguilar-Shea1, C Gallardo-Mayo2

  • 1Medicina Familiar y Comunitaria, Centro de Salud Puerta de Madrid, Atención Primaria de Madrid, Madrid, España.

Semergen
|September 8, 2021
PubMed
Summary
This summary is machine-generated.

Long-acting bronchodilators are key for COPD management. Fixed long-acting muscarinic antagonist/long-acting beta-agonist inhalers offer superior symptom control compared to other combinations in COPD patients.

Keywords:
Chronic obstructive pulmonary diseaseEnfermedad pulmonar obstructiva crónicaExacerbaciónExacerbationInhaler therapyTerapia inhaladora

More Related Videos

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.9K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

Related Experiment Videos

Last Updated: Oct 21, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.9K
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.9K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

Area of Science:

  • Pulmonology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Long-acting bronchodilators form the cornerstone of pharmacological treatment for Chronic Obstructive Pulmonary Disease (COPD).
  • Optimizing inhaled therapy is crucial for improving patient outcomes and disease control.

Purpose of the Study:

  • To compare the efficacy of different inhaled bronchodilator combinations for COPD management.
  • To identify inhaled therapies that provide superior symptom control in non-exacerbating COPD patients.

Main Methods:

  • A systematic literature search was conducted in Medline (PubMed) for comparative studies on inhaler therapy in COPD patients.
  • Analysis focused on studies comparing fixed combinations of long-acting beta-agonists/long-acting muscarinic antagonists (LABA/LAMA) versus long-acting beta-agonists/corticosteroids (LABA/ICS).
  • Further comparisons included individual long-acting muscarinic antagonists (LAMAs) versus long-acting beta-agonists (LABAs) and triple therapy regimens.

Main Results:

  • Fixed LABA/LAMA combinations demonstrated better disease control than LABA/ICS in non-exacerbating COPD patients.
  • Within LABA/ICS combinations, budesonide/formoterol showed superior control.
  • LAMAs alone showed comparable efficacy to LABAs, but offered better control when compared directly to LABAs.
  • Single-device triple therapy was superior to dual therapy and two-device triple therapy, with no significant differences among available single-device combinations.

Conclusions:

  • Fixed LABA/LAMA combinations represent a highly effective treatment strategy for enhancing COPD control.
  • Single-device triple therapy offers advantages over dual therapy and multi-device triple therapy for managing COPD.
  • Treatment decisions should consider the specific combination and delivery device for optimal patient outcomes.